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This report explores the progress Portugal has experienced over the 
last 26 years, in terms of health, well-being, and development, and the 
new challenges it faces as its population grows and ages. This report 
provides information about the diseases and injuries that prevent 
Portuguese from living long and healthy lives. It also sheds light on 
risk factors that contribute to poor health.
Finally, the report presents a country view with regard to the 
Sustainable Development Goals in 1990 and prospectively in 2030, 
and compares Portugal’s health performance to that of peer countries.
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Sustainable Development Goals: the framework
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About the Directorate General  
of Health (DGS)
Mission
To regulate, guide, and coordinate activities to promote health and disease 
prevention, define the technical conditions for providing adequate health 
care, plan and program the national policy for quality in the health system, 
ensure the development and implementation of the National Health  
Plan, and also coordinate the international relations of the Ministry  
of Health.
Its main objective is to contribute to the healthy future of the Portuguese 
population. Its motto is “Better Information, More Health.”
Vision and values
DGS – operating through intersectoral action in a demanding political, 
economic, social, and environmental context, amid continuous innovation 
and demographic transition – considers the determinants that influence the 
individual, family, and collective health and emphasizes the dissemination  
of better information and technical knowledge in an accessible and trans-
parent way.
DGS’s vision is to protect and improve the health and well-being of people 
living in Portugal, ensuring that through quality, safety, and the reduction of 
disparities in health, all can reach their health potential.
Its values are:
• Universality and Equity in Access to Health – Different economic, 
social, family, citizenship, religion, gender, sexual orientation, or other 
factors cannot restrict access to health care in Portugal.
• Scientific Rigor and Ethical Decisions in Health – Health decisions  
are made based on the best existing knowledge in scientific terms and 
application of knowledge, and free of any interest other than the public 
service in health.
• Professionalism, Flexibility, and Collaboration – Rigor and competence 
of professionals, adaptability and spirit of sharing and cooperation with all 
stakeholders in the health system.
• Transparency and Accountability – Accountability and explanation of 
the activities of DGS, proactively and openly.
About IHME
The Institute for Health Metrics and Evaluation (IHME) is an independent 
global health research center at the University of Washington focused on 
expanding the quantitative evidence base for health. IHME aims to provide 
policymakers, donors, and researchers with the highest-quality quantitative 
data to make decisions that achieve better health.
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Foreword
On February 16, 2017, we signed a Memorandum of Understanding (MoU) with IHME to 
improve national-level Global Burden of Disease (GBD) estimates and, over time, develop 
local-level estimates. This momentous event took place at the V National Congress of 
Public Health, where the President of our Republic, Marcelo Rebelo de Sousa, declared, 
“We have a challenge to advance knowledge, to improve information, and to raise a spirit 
of cooperation so that people may have the same vision and goal despite their backgrounds 
or political beliefs: to improve the health of our communities.”
This partnership is important because it allows us to improve the health information 
going into our policy and planning, improve our health systems, and ultimately improve 
the health of our people. 
The problem isn’t having too much data, as one can never have too much data. The 
challenge is how to integrate all of the data. The great advantage of the “GBD approach” to 
health statistics is that it combines the largest catalog of health data in the worldi with tai-
lored methodology for data management, statistical analysis, and presentation to produce 
a comprehensive overview of mortality and health loss for a detailed list of diseases, inju-
ries, and risk factors. This report gives an overview of these results for Portugal covering 
the period 1990–2016. 
Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew 
from two widely used summary measures to monitor such changes in population health, 
namely disability-adjusted life years (DALYs) and healthy life expectancy (HALE). We used 
these measures to track trends and benchmark progress compared with expected trends 
based on the Socio-demographic Index (SDI).
Within the goals of the Memorandum, the nationwide collaboration is an important 
aim, as is the production of scientific papers and reports on the national-level burden  
of disease. 
It is important for us to identify the country’s most pressing health challenges through 
better measurement. IHME says that Portugal is on the verge of becoming another country 
that has successfully used GBD evidence to begin to improve the health of its population. 
The partnership between DGS and IHME is a great example built on a shared vision: 
to help all people to live long and healthy lives. In comparison to some high-income 
countries,ii Portugal had the lowest life expectancy in 1990. Twenty-six years later, life 
expectancy for Portuguese people resembles the high-income countries’ average, mainly 
because of a reduction in premature deaths related to cardiovascular diseases and trans-
port injuries. During this period, there was a significant improvement in disease burden 
related to road injuries, stroke, and ischemic heart disease. On the other hand, Alzhei-
mer’s disease, lung cancer, colorectal cancer, sense organ diseases, low back and neck pain, 
and diabetes increased.
The data and analyses that come from the GBD study are relevant to the Directorate 
General of Health, the Portuguese health system, scientific communities, and the people 
living in Portugal. This is in line with the National Health Plan goals.
Going forward, the Directorate General of Health and IHME will continue to study 
disease burden together, possibly extending to the local level in the future, in collabora-
tion with the Regional Health Administrations. This analysis will shed light on health 
disparities across communities as well as the top diseases, injuries, and risk factors that 
are driving these disparities. Here we want to address and be increasingly responsive to 
the specific needs of local communities.
Graça Freitas
Director General of Health
Lisbon, 23 October 2017 iThe GHDx (IHME’s data library).
iiEU and some OECD countries.
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Preface
In early 2017, the government of Portugal made a national com-
mitment to joining the Global Burden of Disease (GBD) enterprise and 
using the findings from that work to improve the health of the people 
who live in that storied country.
The report here is a testament to the drive of our Portuguese 
collaborators and their willingness to put their words into action. 
This work provides comprehensive, comparable data on both fatal and 
disabling diseases and injuries. It allows for comparisons by condition 
and over time to identify successes and challenges. These estimates 
will help Portugal pinpoint the most pressing health issues and allo-
cate resources accordingly.
Like most higher-income countries, Portugal has undergone 
a demographic and epidemiologic transition over the past three 
decades. Its population is now older on average and experiences more 
nonfatal but disabling health conditions. The country’s national 
health plan aims, by 2020, to increase healthy life expectancy, reduce 
exposure to tobacco smoke, control childhood obesity, and reduce 
mortality among people under 70, all important efforts. The results 
of this study will help the country most effectively address health dis-
parities, prioritize interventions, and fine-tune its health care systems 
to best meet its people’s needs.
Christopher J.L. Murray
Director, IHME
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Disability-adjusted life years (DALYs)
Years of healthy life lost to premature death and suffering. DALYs are 
the sum of years of life lost and years lived with disability.
Expected value
The predicted indicator value based on the country’s per capita income, 
educational attainment, and total fertility rate.
Healthy life expectancy (HALE)
The number of years that a person at a given age can expect to live in 
good health, taking into account mortality and disability.
Observed value
The actual indicator value for the country.
Risk factors
Potentially modifiable causes of disease and injury.
Socio-demographic Index (SDI)
A summary measure of a geography’s sociodemographic development. 
It is based on average income per person, educational attainment, 
and total fertility rate (TFR). SDI contains an interpretable scale: zero 
represents the lowest income per capita, lowest educational attainment, 
and highest TFR observed across all GBD geographies; one represents 
the highest income per capita, highest educational attainment, and 
lowest TFR. Depending on their SDI, countries are classified as high, 
high-middle, middle, low-middle, or low SDI.
Years of life lost (YLLs)
Years of life lost due to premature mortality.
Years lived with disability (YLDs)
Years lived in less than ideal health. This includes conditions that may 
last for only a few days, as well as conditions that can last a lifetime.
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Report highlights
Portuguese are living longer lives
• Life expectancy for Portuguese men and women 
continues to rise. Between 1990 and 2016, life 
expectancy increased by 7.1 years for males 
and 6.1 years for females. Accordingly, the gap 
between male and female life expectancy nar-
rowed.
• Based on its Socio-demographic Index (SDI 
– established on a composite average of the 
ranking of income per capita, average educational 
attainment, and fertility rate), Portugal has a 
higher observed life expectancy than expected.
• On average, Portuguese women born in 2016 will 
live 72.3 years in good health. For Portuguese 
men, healthy life expectancy reaches 68.7 years.
Progress and challenges
• The number of years of life lost (YLLs)iii in Por-
tugal decreased 22.3% between 1990 and 2016. 
This favorable trend was mainly supported by 
decreases in early deaths due to neonatal dis-
orders (decreased 84.6%), transport injuries 
(decreased 73.2%), and a group of other non- 
communicable diseases (decreased 72.7%).
• Attention must be paid to the increasing trend 
of years of life lost due to diabetes, urogenital, 
blood, and endocrine diseases (increased 24.0%) 
and, above all, neurological disorders (increased 
74.1%).
• The leading causes of years lived with disability 
(YLDs) in Portugal are non-communicable 
diseases, mainly musculoskeletal disorders and 
mental and substance use disorders, but also 
other non-communicable diseases (like sense 
organ disorders and skin and subcutaneous 
diseases), neurological disorders, and diabetes, 
urogenital, blood, and endocrine diseases. 
• Disability-adjusted life years (DALYs) are used to 
describe the disease burden. This metric takes 
into account early deaths and disability. Again, 
the non-communicable disease group largely 
surpasses the relative importance of the other 
major groups, namely injuries and communicable, 
maternal, neonatal, and nutritional diseases, in 
terms of health loss among the Portuguese popu-
lation.
• Cancers and cardiovascular diseases are, as 
expected, the main causes of disease burden. 
Musculoskeletal disorders and mental and sub-
stance use disorders, although not major killers, 
are also important causes of health loss.
Preventing death and suffering
• Risk factors are potentially modifiable causes of 
health loss. The main risk factors for early deaths 
in Portugal in 2016 were alcohol and drug use 
(with a fundamental contribution from alcohol 
consumption), poor diet, high systolic blood 
pressure, tobacco consumption, and high body 
mass index, which encompasses obesity and 
overweight. In the period 1990–2016, most of the 
top risk factors registered decreasing trends in 
Portugal, particularly alcohol and drug use (with 
a fundamental contribution from alcohol use), 
dietary risks, and high systolic blood pressure.
Sustainable Development Goals (SDGs): 
country view
• In 2015 the United Nations established the Sus-
tainable Development Goals (SDGs), which specify 
17 universal goals, 169 targets, and 232 indicators 
leading up to 2030. The GBD 2016 study provides 
estimates for 37 health-related SDG indicators, 
and these indicators were used to construct the 
health-related SDG index, a summary measure 
of overall performance across the health-related 
SDGs. Portugal’s SDG index value is increasing, 
although its projected value for 2030 is below 100 
(best performance).
• Concerning the set of 37 health-related SDG 
indicators, Portugal’s best performance is related 
to prevalence rates of stunting and wasting in 
children under 5; proportion of births attended 
by skilled health personnel; malaria incidence; 
prevalence of neglected tropical diseases; uni-
versal access to safe water, safe sanitation, and 
handwashing facilities; prevalence of household 
air pollution; and deaths due to conflict and ter-
rorism.
• Attention must be paid to the following issues, 
identified by poor performance on health-re-
lated SDG indicators for Portugal: prevalence of 
overweight in children aged 2-4 years, incidence 
of HIV infection, deaths due to self-harm, and 
prevalence rates of alcohol consumption, daily 
smoking, and childhood sexual abuse.
Comparing Portugal to its peers
• When compared with its peer countries for pre-
mature mortality, Portugal is significantly better 
than the mean of the high-middle-SDI group for 
ischemic heart disease, stroke, lung cancer, lower 
respiratory infections, chronic obstructive  
pulmonary disease, road injuries, and chronic 
kidney disease, and is significantly worse for  
colorectal cancer, breast cancer, and alcohol- 
related liver disease.
• As far as the total burden of disease is concerned, 
Portugal is significantly better than the mean 
of the high-middle SDI group for ischemic heart 
disease, stroke, sense organ disease, diabetes 
mellitus, lung cancer, chronic obstructive pul-
monary disease, lower respiratory infections, 
road injuries, and falls; it is significantly worse 
for low back and neck pain, depressive disorders, 
migraine, skin diseases, and colorectal cancer.
• Regarding the leading risk factors for premature 
death and compared to the mean of the high- 
middle-SDI group, Portugal is significantly better 
for dietary risks, high blood pressure, tobacco 
use, high body mass index, high fasting plasma 
glucose, high total cholesterol, impaired kidney 
function, air pollution, occupational risks, low 
physical activity, low bone mineral density, and 
child and maternal malnutrition. Portugal is sig-
nificantly worse for unsafe sex.
iiiIn the context of the GBD studies, premature deaths are considered to 
be those occurring before an individual reaches the highest observed 
value in the world for life expectancy in their age group.
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Principais Destaques
Os portugueses vivem mais tempo 
• A esperança de vida dos portugueses continua a 
aumentar. Entre 1990 e 2016, a esperança de vida 
aumentou 7,1 anos para os homens e 6,1 anos para 
as mulheres diminuindo, assim, a diferença entre 
sexos. 
• Portugal tem uma esperança de vida superior à 
esperada, considerando o seu Índice Sociode-
mográfico (SDI – média composta do ranking do 
rendimento per capita, nível educacional médio e 
taxa de fecundidade).
• Em média, as mulheres portuguesas nascidas 
em 2016 viverão 72,3 anos em boa saúde. Para os 
homens portugueses a esperança de vida saudável 
atinge 68,7 anos.
Progressos e desafios
• A mortalidade prematuraiii (medida por anos 
de vida perdidos - YLLs) diminuiu 22,3% em 
Portugal, no período entre 1990 e 2016. Esta 
tendência favorável é, sobretudo, devidaao 
decréscimo das mortes prematuras por afeções no 
período neonatal (decréscimo de 84,6%), acidentes 
de transporte (decréscimo de 73,2%) e um grupo 
de outras doenças não transmissíveis (decréscimo 
de 72,7%).
• Especial atenção deve ser dada à tendência cres-
cente dos anos de vida perdidos por diabetes, 
doenças do aparelho génito-urinário, doenças do 
sangue e doenças endócrinas (aumento de 24,0%) 
e, acima de tudo, por perturbações neurológicas 
(aumento de 74,1%). 
• As principais causas de anos vividos com inca-
pacidade (YLDs) em Portugal são as doenças não 
transmissíveis, principalmente, as perturbações 
músculo-esqueléticas, as perturbações mentais 
e as associadas ao consumo de substâncias, bem 
como  outras doenças não transmissíveis (como  
perturbações dos órgãos dos sentidos e as doenças 
da pele e do tecido subcutâneo),  as perturbações 
neurológicas, a diabetes, as doenças do aparelho 
génito-urinário, e do sangue, e as doenças endó-
crinas.
• Os anos de vida ajustados à incapacidade (DALYs) 
são usados para descrever a carga da doença. Esta 
métrica leva em conta as mortes prematuras e a 
incapacidade. De novo, em termos da perda de 
saúde da população portuguesa, o grande grupo 
das doenças não transmissíveis ultrapassa larga-
mente a importância relativa dos outros grandes 
grupos de causas, nomeadamente, as lesões e as 
doenças transmissíveis, maternas, neonatais e 
nutricionais.
• As neoplasias e as doenças cardiovasculares são, 
como esperado, as principais causas de carga da 
doença. As perturbações músculo-esqueléticas, as 
perturbações mentais e as associadas aoconsumo 
de substâncias, apesar de não serem grandes 
causas de morte, também são causas importantes 
de perda de saúde dos portugueses.
Prevenindo morte e sofrimento
• Os fatores de risco são causas potencialmente 
modificáveis de perda de saúde. Os principais 
fatores de risco para a mortalidade prematura 
em Portugal em 2016 são o consumo de álcool e 
drogas (fundamentalmente à custa do consumo 
de álcool), a dieta inadequada, a pressão arterial 
elevada, o consumo de tabaco e o índice de massa 
corporal elevado, que engloba a pré-obesidade e a 
obesidade. No período 1990-2016, a maioria dos 
principais fatores de risco apresentou tendências 
decrescentes em Portugal. Em particular, o 
consumo de álcool e drogas, a dieta inadequada e 
a pressão arterial elevada.
Objetivos de Desenvolvimento Suste-
ntável (SDG): uma perspectiva nacional
• Em 2015 as Nações Unidas estabeleceram os 
Objetivos de Desenvolvimento Sustentável (SDG), 
que especificam 17 objetivos universais, 169 metas 
e 232 indicadores a atingir até 2030. O estudo GBD 
2016 produziu estimativas para os 37 indicadores 
SDG relacionados com a saúde. Estes indicadores 
foram utilizados para o cálculo do índice SDG 
relacionado com a saúde, uma medida síntese do 
desempenho global de cada país relativamente aos 
SDG relacionados com a saúde. Para Portugal a 
evolução dos valores anuais deste índice tem sido 
crescente e, portanto, positiva, apesar do valor 
projetado para o ano 2030 se encontrar abaixo de 
100 (o melhor desempenho). 
• No conjunto dos 37 indicadores SDG relacionados 
com a saúde, os melhores resultados em Portugal 
encontram-se relacionados com a  prevalência 
de malnutrição crónica e aguda nas crianças 
abaixo dos 5 anos, a proporção de nascimentos 
assistidos por profissionais de saúde habilitados, 
a incidência de malária, a prevalência de doenças 
tropicais negligenciadas, o acesso universal a 
sistemas públicos de abastecimento de água e 
saneamento e a lavabos, a prevalência de poluição 
do ar interior e, ainda, às mortes por por conflitos 
e terrorismo. 
• Deve ser dada especial atenção aos aspetos rel-
acionados com os piores resultados ,alcançados 
por Portugal no conjunto dos 37 indicadores: 
a prevalência de excesso de peso em crianças 
dos 2 aos 4 anos, a incidência da infeção por 
VIH, as mortes por lesões autoprovocadas e as 
prevalências de consumo de álcool, consumo 
diário de tabaco e  abuso sexual de crianças.
Comparando Portugal com os seus 
pares
• A mortalidade prematura em Portugal é significa-
tivamente inferior à média dos seus pares (grupo 
de países de alto-médio SDI, no qual Portugal 
se encontra incluído) para a doença isquémica 
cardíaca, doença cerebrovascular, cancro do 
pulmão, infeções das vias respiratórias inferiores, 
doença pulmonar obstrutiva crónica, acidentes de 
transporte e doença crónica dos rins, e significa-
tivamente pior parao cancro colorretal, cancro da 
mama e as doenças hepáticas associadas ao álcool.
• No que respeita à carga global da doença, Portugal 
encontra-se significativamente melhor do que a 
média dos seus pares (países de elevado-médio 
rendimento) para a doença isquémica cardíaca, 
doença cerebrovascular, doenças dos órgãos dos 
sentidos, diabetes, cancro do pulmão, doença pul-
monar obstrutiva crónica, infeções respiratórias 
inferiores, acidentes de transporte e quedas; 
encontra-se significativamente pior em relação às 
dores lombares (lombalgias) e do pescoço, pertur-
bações depressivas, enxaqueca, doenças da pele e 
cancro colorretal. 
• Quanto aos principais fatores de risco para a 
morte prematura e comparando com a média do 
grupo de países de médio-elevado SDI, Portugal 
encontra-se significativamente melhor para os 
seguintes fatores de risco: dieta inadequada, 
hipertensão arterial, consumo de tabaco, índice 
de massa corporal elevado, glicemia em jejum 
aumentada, colesterol total elevado,  alteração da 
função renal, poluição do ar, riscos ocupacionais, 
baixa atividade física, densidade mineral óssea 
baixa e nutrição materna e infantil inadequada. 
Portugal encontra-se significativamente pior em 
relação aosexo não seguro. 
iiiNo contexto dos estudos GBD, consideram-se mortes prematuras as que 
ocorrem antes do indivíduo atingir o valor mais elevado observado no 
mundo para a esperança de vida no seu grupo etário.
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Findings
Portuguese are living longer lives
Over recent years, the lives of Portuguese people have seen note-
worthy improvements in health (Figure 1). Life expectancy for men and 
women has risen since 1990. Life expectancy increased by 7.1 years for 
males (70.7 years in 1990 to 77.8 years in 2016) and 6.1 years for females 
(77.9 years in 1990 to 84.0 years in 2016) between 1990 and 2016. 
During this period, the gap between male and female life expectancy 
narrowed, decreasing from 7.2 years in 1990 to 6.2 years in 2016.
Though considered a high-income country, Portugal has a high-
middle Socio-demographic Index (SDI – established on a composite 
average of the ranking of income per capita, average educational 
attainment, and fertility rate). Based on its SDI, Portugal had a higher 
observed life expectancy than expected.
For females, observed life expectancy surpassed expected values by 
1.6 years in 1990 and by 5.0 years in 2016. For males, the changes were 
even more noteworthy: from 0.5 to 5.1 years for the same time period.
According to GBD 2016 estimates, on average, Portuguese women 
born in 2016 will live 72.3 years in good health, which represents 86% 
of female life expectancy.  
Figure 1
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Portuguese men born in the same year on average will live 68.7 years in 
good health, a slightly larger proportion of male life expectancy (88%).
Even though the Portuguese are living longer, the number of years 
lived in full health (healthy life expectancy, HALE) did not increase by 
the same proportion (Table 1). From 1990 to 2016, the gap between 
life expectancy and healthy life expectancy for males and females 
increased, being higher for females. HALE rose 6.0 years for males and 
5.1 years for females between 1990 and 2016.iv 
In 2016, Portugal had the 13th highest life expectancy for females 
and the 33rd highest life expectancy for males in the world (Table 2). 
Life expectancy for females was higher than in other countries such as 
Greece, Germany, the United Kingdom (UK), and Denmark. However, 
Spain, France, and Italy had higher life expectancy for females than 
Portugal.
Comparing life expectancy for males in Portugal with other coun-
tries, Portugal ranked worse than Greece, Germany, UK, Denmark, 
Spain, France, and Italy.
Table 1
Life expectancy and HALE among males and females, Portugal, 1990–2016
Life expectancy (LE) Healthy life expectancy (HALE) Difference between LE and HALE
1990 2016 1990 2016 1990 2016
Females 77.9 84.0 67.2 72.3 10.7 11.7
Males 70.7 77.8 62.7 68.7 8.0 9.1
ivConsult methodological note.
National Health Plan – revision and extension to 20201
There are four goals for the National Health Plan – revision and extension to 2020. Portugal has 
a low birth rate and an aging population with multiple chronic illnesses. It has been experiencing 
a demographic and epidemiological transition. 
The four goals defined for 2020 are:
• Reducing mortality under 70 years old;
• Increasing healthy life expectancy;
• Reducing tobacco consumption and secondhand smoke (in the population 15 years or older);





Increase healthy life 
expectancy by at least 30%:  
Healthy life expectancy has 
increased in Portugal for 
both males and females.
Table 2
Top 35 (of 195) countries and territories with the highest life expectancy and healthy life expectancy 
in the world, 2016
LE, Females, 2016 HALE, Females, 2016 LE, Males, 2016 HALE, Males, 2016
Rank Location Years Rank Location Years Rank Location Years Rank Location Years
1 Japan 86.9 1 Singapore 75.2 1 Singapore 81.3 1 Singapore 72.0
2 Singapore 86.1 2 Japan 75.1 2 Switzerland 81.0 2 Spain 71.2
3 Andorra 85.8 3 Spain 74.0 3 Japan 80.8 3 Japan 71.1
4 Spain 85.6 4 France 73.4 4 Iceland 80.6 4 Switzerland 71.0
5 France 85.4 5 Andorra 73.0 5 Australia 80.5 5 Iceland 70.8
6 Switzerland 85.2 6 South Korea 73.0 6 Spain 80.3 6 Italy 70.5
7 Italy 84.6 7 Italy 72.9 7 Luxembourg 80.3 7 Australia 70.4
8 Finland 84.6 8 Switzerland 72.9 8 Sweden 80.1 8 Israel 70.4
9 Australia 84.6 9 Costa Rica 72.9 9 Norway 80.1 9 Norway 70.3
10 South Korea 84.2 10 Australia 72.7 10 Israel 80.0 10 Luxembourg 70.1
11 Israel 84.1 11 Norway 72.7 11 Kuwait 80.0 11 Sweden 70.1
12 Norway 84.1 12 Israel 72.5 12 Italy 79.9 12 Canada 70.0
13 Portugal 84.0 13 Canada 72.3 13 Canada 79.8 13 France 69.9
14 Iceland 84.0 14 Portugal 72.3 14 Netherlands 79.6 14 Netherlands 69.9
15 Sweden 84.0 15 Austria 72.2 15 New Zealand 79.5 15 New Zealand 69.8
16 Luxembourg 83.9 16 Finland 72.2 16 Andorra 79.3 16 Malta 69.7
17 Canada 83.9 17 Iceland 72.2 17 France 79.2 17 Austria 69.5
18 Austria 83.9 18 Malta 72.2 18 Austria 79.1 18 Costa Rica 69.5
19 Malta 83.8 19 Taiwan 72.1 19 Malta 79.0 19 Andorra 69.4
20 Slovenia 83.8 20 Greece 72.0 20 Qatar 79.0 20 Ireland 69.3
21 Netherlands 83.6 21 New Zealand 71.8 21 Ireland 79.0 21 Greece 69.2
22 Costa Rica 83.6 22 Chile 71.7 22 United Kingdom 78.9 22 United Kingdom 69.1
23 Greece 83.5 23 Luxembourg 71.7 23 Finland 78.9 23 Kuwait 69.0
24 New Zealand 83.4 24 Bermuda 71.7 24 Lebanon 78.8 24 Cyprus 69.0
25 Belgium 83.4 25 Sweden 71.7 25 Denmark 78.8 25 Denmark 68.9
26 Germany 83.3 26 Ireland 71.6 26 Germany 78.5 26 Germany 68.9
27 Ireland 83.3 27 Panama 71.6 27 Costa Rica 78.5 27 Finland 68.8
28 Chile 83.2 28 Netherlands 71.5 28 Greece 78.4 28 Belgium 68.8
29 United Kingdom 82.9 29 Germany 71.5 29 Belgium 78.4 29 Portugal 68.6
30 Denmark 82.8 30 Slovenia 71.5 30 Cyprus 78.1 30 Peru 68.6
31 Taiwan 82.8 31 Cyprus 71.5 31 Slovenia 77.8 31 South Korea 68.5
32 Cyprus 82.8 32 Belgium 71.4 32 Peru 77.8 32 Taiwan 68.4
33 Bermuda 82.4 33 Puerto Rico 71.3 33 Portugal 77.8 33 Maldives 68.2
34 Puerto Rico 82.4 34 Colombia 71.1 34 South Korea 77.7 34 Chile 68.0
35 Turkey 82.3 35 Peru 71.0 35 Maldives 77.6 35 Lebanon 67.9
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Regarding healthy life expectancy, Portugal ranked 14th for females 
and 29th for males in 2016.
The proportion of deaths under 70 years of the total number of 
deaths (all ages) showed a steady decrease over the period 1990–2016 
(Figure 2).
From 1990 to 2016, Portugal saw a decrease in the number of child 
deaths. The under-5 mortality rate dropped from an initial value of 
14.2 deaths per 1,000 live births in 1990 to 3.1 by 2016. A similar trend 
was observed for the infant mortality rate, which decreased from 11.3 
infant deaths per 1,000 live births to 2.5 in the same period (Figure 3). 
The improvement in living conditions2 and of child and maternal health 
care (mainly perinatal care organization and primary health care) are 
considered to be responsible for this progress.3
As is the case for life expectancy, child mortality rates in Por-
tugal are better than expected based on the country’s SDI, and the gap 



































































Reduce the proportion of 
mortality in people under 
70 years old to below 20%: 
In 2016 this mortality 
proportion reached 
21.2%, following a steadily 
decreasing trend.
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Figure 4
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Life expectancy
76 77 78 79 8474 75 80 81 82 83
76 77 78 79 8474 75 80 81 82 83
Portugal (6.7 years) -0.04 +6.7































United States (3.4 years)
-0.48 +3.89
Progress and challenges
Figure 4 shows changes in country life expectancy at birth by broad 
cause group for both sexes between 1990 and 2016.v 
In comparison to the other high-income countries in Figure 4, 
Portugal had the lowest life expectancy in 1990 (74.0 years). Twenty-six 
years later, life expectancy for Portuguese people resembles the average 
in high-income countries (81.0 years), mainly because of a reduction in 
premature deaths due to cardiovascular diseases and transport injuries.
Premature death (measured as YLLs) in Portugal occurs largely 
because of stroke and ischemic heart disease (Figure 5). Between 1990 
and 2016, early deaths decreased 22.3%. While in 1990 stroke was the 
leading cause of early death, in 2016 it ranked second. Early deaths due 
to this cause decreased approximately 54%. Even though ischemic heart 
disease shifted from second to first position in the same period of time, 
early deaths caused by this disease reduced by 35.8%.
Figure 5






































































































































vPortugal is a member state of the European 
Union (EU) and the Organisation for Economic 
Co-operation and Development (OECD), being 
considered a high-income country. In this 
regard, for comparison, we’ve considered 
member states of both the EU and the OECD.
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Due to longer life expectancies and an aging population, the propor-
tion of early deaths from Alzheimer’s disease increased considerably 
(89.8%) between 1990 and 2016 among males (91.2%) and females (89.1%).
The decreases in early deaths related to road injuries (75.3%), neonatal 
preterm birth complications (90.3%), and congenital defects (78.5%) were 
considered major achievements of this period.
Early deaths from cancers have also changed during this period. 
Regarding lung cancer, early deaths increased 40.5% overall: 34.4% for 
males and 68.1% for females. This difference is explained by the change 
in smoking habits among women.4 Early deaths from colorectal cancer 
have increased 36.9% (54.0% for males and 16.9% for females). Neverthe-
less, early deaths from stomach cancer decreased during this period for 
both males and females. 
In females, early deaths caused by cancers that are included in pop-
ulation-based screening programs (such as breast and cervical cancers) 
decreased from 1990 to 2016. Early deaths from breast cancer decreased 
10.5%, while early deaths caused by cervical cancer decreased 28.6%. 
Figure 6
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For males, early deaths due to prostate cancer increased 26.8% during 
the same period. This increase is likely due, in part, to the effects of an 
aging population, and screening efforts may be effective in stemming 
this upward trend.
Leading causes of early deaths in the Portuguese population are 
different according to age group. Neonatal disorders, diarrhea, lower 
respiratory diseases, and other common infectious diseases are the 
main causes of infant deaths. The post-neonatal period coincides with 
the increasing importance of deaths due to injuries, which peak in the 
20-24 year age group. Non-communicable diseases, mainly cancers and 
cardiovascular diseases, are the major causes of years of life lost among 
the Portuguese population aged 35 or older. Early deaths due to HIV/
AIDS and tuberculosis account for a higher proportion in people aged 
25-49 years (Figure 6).
As Portuguese live longer lives, they increasingly suffer from 
disabling conditions, which contribute to YLDs. The most recent GBD 
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Figure 7
Distribution of total YLDs by cause of disability (%), both sexes, Portugal, 2016
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municable diseases as the leading cause of years lived with disability 
(88.5% of total YLDs). Other major groups of conditions account for 7.1% 
(injuries) and 4.5% (communicable, maternal, neonatal, and nutritional 
diseases) of total YLDs.
Drilling down in these major groups (Figure 7) reveals the high 
proportion of musculoskeletal disorders and mental and substance use 
disorders in the total number of years Portuguese spent living with 
disability: 23.0% and 19.0%, respectively.  
Neurological disorders (10.0%), diabetes, urogenital, blood, and endo-
crine diseases (6.8%), and other NCDs (18.3%) complete the top five 
causes of disability at this level of analysis. Conditions responsible for 
most deaths, like cardiovascular diseases, chronic respiratory diseases, 
and cancers, do not stand out as major causes of disability in the  
Portuguese population.
Deepening the level of analysis makes it possible to identify sense 
organ diseases (8.0%) and skin and subcutaneous diseases (6.1%) as 
principal contributors to the “other NCD” group mentioned above.
Figure 8
Leading causes of disability (YLDs) and percent change, both sexes, Portugal, 1990–2016
1990 Ranking


































































































































viIt is only since 2011 that there is a National 
Guideline for the diagnosis of dementias 
(Guideline #53 - Abordagem Terapêutica das 
Alterações Cognitivas) http://www.dgs.pt/
ms/8/paginaRegisto.aspx?back=1&id=21604
Some similarities and differences arise when comparing 1990 and 
2016 rankings of causes of disability for Portuguese people (Figure 
8). Low back and neck pain remains as the most common cause of 
disability, with increasing importance in total YLDs (15.9% in 1990 to 
16.7% by 2016, a percentage change of 22.8%). Disability has also risen 
for sense organ diseases (37.4%), other musculoskeletal diseases (40.9%), 
osteoarthritis (59.8%), and Alzheimer’s disease (94.2%). Disability from 
diabetes increased 52.2% in this period. 
Years lived with disability decreased for falls (3.7%), asthma (3.7%), 
other cardiovascular diseases (12.1%), and road injuries (25.1%) in the 
1990–2016 time period.
Between 1990 and 2016, years lived with disability for males 
increased 35.9% for sense organ diseases, 62.3% for diabetes, and 31.4% 
for oral disorders. Disability caused by HIV/AIDS increased 794.3%, 
ranking as the 10th leading cause of disability in 2016. It should be 
noted that in 1990 the prevalence of HIV/AIDS in Portugal was still very 
low.
Between 1990 and 2016, disability for females increased 33.3% for 
oral disorders, 43.7% for diabetes, and 60.4% for osteoarthritis. Years 
lived with disability due to Alzheimer’s disease increased 94.4% in the 
same period. It should be remarked that in 1990 Alzheimer’s disease 
prevalence was not known5 and it most probably was under- or misdi-
agnosed.vi
Disability-adjusted life years (DALYs), which describe the disease 
burden, provide a fuller understanding of health problems. This metric 
takes into account early deaths and disability.
Again, the major group of NCDs largely surpasses the relative impor-
tance of injuries and communicable, maternal, neonatal, and nutri-
tional diseases in terms of health loss in the Portuguese population due 
to premature death or disability. The most recent GBD results indicate 
that NCDs accounted for 86.5% of total DALYs, injuries contributed 7.7%, 
and the remaining conditions contributed 5.8%. Based on Portugal’s 
level of development (measured by its SDI), the expected distribution 
of causes of disease burden was slightly different from the observed 
distribution, with less contribution of NCDs (81.3% of total DALYs) and 
higher levels of injuries (11.9%) and communicable, maternal, neonatal, 
and nutritional diseases (6.9%). 
Cancers and cardiovascular diseases were, as expected, the main 
individual causes of disease burden, with 17.7% and 17.0% of total 
DALYs, respectively. Musculoskeletal disorders and mental and sub-
stance use disorders, although not major killers, were responsible for 
10.9% and 9.2%, respectively, of the total disease burden of Portuguese 
people (Figure 9). This finding is not surprising given that they were 
also the top two causes of YLDs.
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In 1990, the leading causes of disease burden in both sexes were 
stroke, ischemic heart disease, low back and neck pain, road injuries, 
and depressive disorders. For 2016, low back and neck pain was the 
leading cause, followed by ischemic heart disease, stroke, Alzheimer’s 
disease, and sense organ diseases (Figure 10). 
Between 1990 and 2016, there was a strong decrease in disease 
burden related to road injuries (67.8%), stroke (49.1%), and ischemic 
heart disease (33.5%). However, during the same time period, there was 
an increase in disease burden related to Alzheimer’s disease (90.8%), 
lung cancer (40.6%), colorectal cancer (38.8%), sense organ diseases 
(37.4%), low back and neck pain (22.8%), and diabetes (20.0%).
Looking at differences among males and females, disease burden 
due to colorectal cancer increased 56.0% for males between 1990 and 
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Figure 9
Distribution of total DALYs by cause of disease burden (%), both sexes, Portugal, 2016
Figure 10
Leading causes of disease burden (DALYs) and percent change, both sexes, Portugal, 1990–2016
1990 Ranking 2016 Ranking
Stroke
Ischemic heart disease































































































































Males had an increase of 220.4% in the disease burden associated 
with HIV/AIDS between 1990 and 2016. As mentioned before, in 1990 
HIV/AIDS prevalence in Portugal was very low.
Stomach cancer disease burden decreased in the same period for 
both males (28.6%) and females (38.0%).
Breakdown of total disease burden by age group in Portugal reveals 
that in the first year of life the leading causes of health loss are neonatal 
disorders, other NCDs (mainly congenital birth defects), and diarrhea, 
lower respiratory infections, and other common infectious diseases. 
The main causes of disease burden for children aged 1-4 years are other 
NCDs (mainly skin and subcutaneous diseases); diarrhea, lower respi-
ratory infections, and other common infectious diseases; and unin-
tentional injuries. Mental and substance use disorders are the second 
leading cause of disease burden (following other NCDs) in age groups 
5-9 and 10-14 years, rising to the top position for people aged 15 to 39 
years. For young adults (20-39 years), musculoskeletal disorders are 
an important cause of health loss. After 40 years of life, much of the 
disease burden is caused by cancers, but also by musculoskeletal disor-
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ders and mental and substance use disorders. Cardiovascular diseases 
become increasingly important for Portuguese after 55 years of life. For 
the older population (80+ years) neurological disorders are also a main 
cause of disease burden (Figure 11).
Preventing death and suffering 
Risk factors represent potentially modifiable causes of the diseases 
and injuries that contribute to ill health. Therefore, addressing them 
could drastically reduce Portugal’s burden of disease. 
GBD classifies risk factors into three categories: behavioral, meta-
bolic, and environmental and occupational.
In 2016, roughly 41% of all years of life lost prematurely in Portugal 
could have potentially been avoided by addressing all behavioral risk 
factors. Removing the detrimental effects of metabolic risk factors 
alone could have prevented 28% of years lost due to early death.
Figure 11
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The main risk factor for early mortality in Portugal in 2016 was 
alcohol and drug use (Figure 12), with a major contribution from 
alcohol consumption. Overall, approximately 242,307 years of life 
could be gained if alcohol consumption in Portugal was dramatically 
reduced.
The main diseases related to alcohol and drug use included cardio-
vascular diseases (74,374 YLLs), cancers (67,573 YLLs), and cirrhosis and 
other chronic liver diseases (39,541 YLLs).
The second most important risk factor in 2016 was poor diet. Just 
over 237,000 years of life could be saved if Portuguese people improved 
their eating habits. As with alcohol consumption, this behavioral risk 
factor contributed to early death mostly through cardiovascular dis-
eases (180,624 YLLs) and cancers (39,216 YLLs).
The third-leading risk factor was metabolic: high systolic blood 
pressure. Roughly 226,000 years of life were lost in 2016 due to elevated 
blood pressure levels. It was an essential contributor to early deaths 
from cardiovascular diseases (207,067 YLLs) and diabetes, urogenital, 
and endocrinological conditions (19,071 YLLs).
Fourth, tobacco consumption was an important risk factor, con-
tributing to premature mortality from several diseases, such as cancers 
(117,906 YLLs), cardiovascular diseases (47,351 YLLs), and chronic respi-
ratory diseases (32,570 YLLs).  
Figure 12
Leading risk factors contributing to early death (YLLs) and percent change, both sexes, Portugal, 
1990–2016
1990 Ranking 2016 Ranking
Alcohol and drug use
High systolic blood pressure
Dietary risks
Tobacco
High body mass index
High total cholesterol
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Overall, if tobacco consumption was greatly reduced, Portugal could 
gain up to 216,000 years of life.
The fifth most important risk factor was also metabolic. High body 
mass index, which encompasses obesity and overweight, was respon-
sible for just over 162,000 years of life lost prematurely. It was also a 
main contributor to cardiovascular diseases (82,849 YLLs), diabetes and 
other endocrinological conditions (34,477 YLLs), and cancers  
(28,180 YLLs).
Looking at the most important changes and trends between 1990 
and 2016 in Portugal, several messages are noteworthy.
On one hand, most of the top risk factors, either metabolic or 
behavioral, registered decreasing trends during this period, particularly 
alcohol and drug use (down 37.8%), dietary risks (down 37.7%), and high 
systolic blood pressure (down 43.5%). Additionally, the contribution of 
air pollution to premature mortality has decreased considerably (down 
55.9%). While there have been slight decreases in ambient particulate 
matter exposure, the majority of the decrease in attributable premature 
mortality was due to changes in the outcomes themselves. Between 
1990 and 2016, Portugal has seen positive changes in premature 
mortality due to many NCDs. Two outcomes tied to air pollution that 
decreased substantially during this period were stroke and ischemic 
heart disease (from 339,000 and 273,000 YLLs in 1990 to 156,000 and 
176,000 in 2016, respectively). 
On the other hand, unsafe sex has registered an upward trend 
(32.9%), probably resulting from changing sexual habits and practices. 
In the risk factor estimates, 100% of the burden of cervical cancer 
and sexually transmitted diseases (excluding HIV) was attributed to 
unsafe sex. Then, the proportion of HIV that was transmitted sexually 
was modeled. Most of the sources for HIV transmission report HIV 
transmission modes for all ages and both sexes combined, but for GBD 
2016 those data were split for the first time according to an estimated 
age-pattern. This likely accounts for some of the change in the unsafe 
sex burden between GBD 2015 and GBD 2016, especially for particular 
age groups.
Most of the change in burden attributable to unsafe sex was due to 
a change in the underlying HIV burden estimates between GBD 2015 
and GBD 2016 (the HIV burden for Portugal increased by 25%, from 289 
to 362 DALYs per 100,000). Since the majority of the estimated unsafe 
sex burden comes from HIV, this shift made a noticeable difference. 
While comparing 1990 burden to 2016 burden does seem to indicate an 
alarming trend, it is misleading to do so, as the burden from unsafe sex 
actually peaked in 2000 and has been declining since.
In Figure 13 we can observe differences between risk factors for 
males and females.
While for males, alcohol and drug use and tobacco consumption are 
the main drivers of premature mortality, for females these are dietary 
risks and elevated blood pressure. For both sexes, these top risk factors 
mainly contributed to early deaths through cardiovascular and neo-
plastic disorders.
Despite improvements in reducing exposure, a segment of the  
population in Portugal has a high alcohol consumption level, based 
on sales data and surveys. The ranking of alcohol and drug use as the 
country’s top risk factor in terms of DALYs is reflective of the increased 
risk associated with alcohol, compared to GBD 2015, which was  
established this past year through a new meta-analysis.  
Figure 13
Top risk factors for early death (YLLs) by cause, males and females, Portugal, 2016
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Most of the other large risk factors, like smoking and high blood pres-
sure, also decreased more than alcohol use, contributing to its con-
tinued position as the number-one risk.
Top risk factors contributing to premature deaths (YLLs) as well as 
to total disease burden (DALYs) in the Portuguese population have been 
identified and addressed in national health policies such as the National 
Health Plan1 and associated Priority Health Programs.1 Reducing 
tobacco consumption and secondhand smoke along with controlling 
childhood obesity are main goals of the NHP.
Sustainable Development Goals: country view
Between 1990 and 2016, Portugal achieved notable gains on most of 
the 37 health-related Sustainable Development Goals indicators (Figure 
14). From an initial SDG index value of 53 for 1990, it is expected, on 
the basis of past trends, that the SDG index for Portugal will reach 78 
by 2030 after having reached 70 in 2016 (see Methodological notes 
regarding the framework of Sustainable Development Goals and how to 
interpret Figure 14).
The health-related indicator associated with SDG 1 (“End poverty in 
all its forms everywhere”) is the death rate due to exposure to forces of 
nature (per 100,000 population). Portugal can be considered a country 
with low natural disaster mortality, although according to GBD 2016 
estimates, the death rate due to exposure to forces of nature rose from 
0.005 to 0.03 per 100,000 population in the period 1990–2016, an unfa-
vorable trend.
Three health-related indicators are associated with SDG 2 (“End 
hunger, achieve food security and improved nutrition, and promote sus-
tainable agriculture”). Portugal made progress in prevalence of stunting 
and prevalence of wasting in children under 5. GBD estimates for the 
period 1990–2016 show decreases of 51.2% and 32.3%, respectively. Of 
concern is the increase in prevalence of overweight in children aged 
2-4 years, the third health-related indicator of Goal 2. Between 1990 
and 2016, prevalence of overweight in this age group rose from 20.7% to 
31.7%, according to GBD 2016 estimates for Portugal.
SDG 3, which aims to “ensure healthy lives and promote wellbeing 
for all at all ages,” encompasses 21 health-related indicators that exist 
within 11 health-related targets. Portugal has already reached 2030 
targets for indicators “Age-standardized rate of malaria cases” and 
“Proportion of births attended by skilled health personnel.” Indicator 
“Age-standardized prevalence of the sum of 15 neglected tropical dis-
eases” is also very close to its target for 2030 (index value of 99 esti-
mated for 2016). Indicators related to neonatal mortality and under-5 
mortality have been declining steadily in Portugal, and their estimates 
for 2016 are well below 2030 targets. Vaccine coverage in target pop-
ulations reached 95.1% (which corresponds to an index value of 92) by 
2016. Most of the other health-related indicators associated with SDG 
3 have index values above 75 and have been improving since 1990. It 
is worth mentioning the universal health coverage (UHC) index, which 
measures progress toward SDG target 3.8 (“achieve universal health 
coverage, including financial risk protection, access to quality essential 
health-care services and access to safe, effective, quality, and affordable 
essential medicines and vaccines for all”). Results for Portugal show 









































































































































































































































































































































































































































































































































































































































































































































Control child obesity:  
Available data for Portugal 
show high and increasing 
prevalence of child 
overweight and obesity 
over time. However, more 
recent studies appear to 
show that the prevalence 
of overweight and obesity 




38        Portugal: The Nation’s Health 1990–2016 Findings        39 
The set of health-related indicators associated with SDG 3 (“Ensure 
healthy lives and promote well-being for all at all ages”) on which 
Portugal performed worst (index values for 2016 below 50) were 
risk-weighted prevalence of alcohol consumption as measured by the 
summary exposure value for alcohol use, age-standardized rate of 
new HIV infections, age-standardized prevalence of daily smoking in 
populations aged 10 and older, and age-standardized death rate due to 
self-harm.
The health-related indicator associated with SDG 5 (“Achieve gender 
equality and empower all women and girls”) is the age-standardized 
prevalence of women aged 15 years and older who experienced phys-
ical or sexual violence by an intimate partner in the last 12 months. In 
Portugal this prevalence decreased from 20.3% to 14.2% in the period 
1990–2016.
SDG 6 aims to “ensure availability and sustainable management 
of water and sanitation for all.” Its health-related indicators are risk-
weighted prevalence of populations using unsafe or unimproved water 
sources, risk-weighted prevalence of populations using unsafe or unim-
proved sanitation, and risk-weighted prevalence of populations without 
access to a handwashing facility. Portugal performs well regarding uni-
versal access to safe water, safe sanitation, and handwashing facilities, 
with index values equal to or above 95 for all three indicators.
Progress toward SDG 7 (“Ensure access to affordable, reliable, and 
sustainable modern energy for all”) and health-related target 7.1 (“By 
2030, ensure universal access to affordable, reliable and modern energy 
services”) is measured by the indicator risk-weighted prevalence of 
household air pollution. Again, estimates for Portugal indicate prog-
ress: prevalence values decreased from 7.3% by 1990 to 0.6% by 2016. 
SDG 8 aims to “promote sustained, inclusive and sustainable eco-
nomic growth, full and productive employment and decent work for 
all.” Age-standardized all-cause disability-adjusted life year (DALY) 
rates attributable to occupational risks is the indicator chosen to mea-
sure progress toward health-related target 8.8 (“Protect labour rights 
and promote safe and secure working environments for all workers, 
including migrant workers, in particular women migrants, and those in 
precarious employment”). Although this indicator shows a decreasing 
trend in Portugal, the most recent estimate (for 2016) reached 746.8 
DALYs per 100,000, corresponding to an index value of 78.
“Make cities and human settlements inclusive, safe, resilient, and 
sustainable” is the ambition of SDG 11. The health-related indicator 
associated with SDG 11 is population-weighted mean levels of fine par-
ticulate matter smaller than 2.5 microns in diameter (PM2.5). According 
to GBD 2016 estimates, Portugal made little progress in terms of 
improving air quality in the period 1990–2016: PM2.5 decreased only 
minimally, from 10.0 to 9.5 µg per cubic meter.
SDG 16 aims to “promote peaceful and inclusive societies for 
sustainable development, provide access to justice for all and build 
effective, accountable, and inclusive institutions at all levels.” Three 
health-related indicators are associated with target 16.1 (“Significantly 
reduce all forms of violence and related death rates everywhere”) and 
estimates for age-standardized death rate due to interpersonal violence, 
death rate due to conflict and terrorism, and age-standardized preva-
lence of physical or sexual violence experienced by populations during 
the previous 12 months in Portugal show low values and decreasing 
trends in the study period. Progress toward target 16.2 (“End abuse, 
exploitations, trafficking and all forms of violence against and torture 
of children”) is measured by the indicator age-standardized preva-
lence of women and men aged 18-29 years who experienced sexual 
violence by age 18. Portugal made no progress in terms of prevalence 
of childhood sexual abuse, with a value of 11.2% throughout the period 
1990–2016, well above the indicator target for 2030 (equal to or less 
than 0.5%).
In relation to SDG 17 (“Strengthen the means of implementation 
and revitalize the global partnership for sustainable development”), 
Portugal shows an increasing trend for the health-related indicator 
associated with this goal: percentage of well-certified deaths by a vital 
registration system among a country’s total population. The 2016 esti-
mate (79.3%) is very close to this indicator’s target for 2030 (equal to or 
greater than 80%).
The estimates for Portugal and for 2016 are detailed in Annex 1. 
This table presents each unscaled value associated with its SDG Goal, 
Target, Indicator description, and Indicator target.
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Comparing Portugal to its SDI group 
country peers
SDI is a summary measure of a location’s sociodemographic devel-
opment and is based on income, education, and fertility rate. Por-
tugal was classified as a high-middle-SDI country and, for comparison 
purposes, we’ve considered the same peer countries used in the GBD 
country profiles found at www.healthdata.org/country-profiles. The 
comparison group was chosen based on the GBD regional classifications, 
known trade partnerships, and sociodemographic indicators. For the 
identification of statistical significance,  
the estimate for the high-middle-SDI group was chosen as the  
reference point.
When compared with its peer countries for premature mortality 
(YLLs), Portugal did significantly better than the mean of the high- 
middle-SDI group in 2016 for ischemic heart disease, stroke, lung 
cancer, lower respiratory infections, COPD, road injuries, and chronic 
kidney disease. For colorectal cancer, breast cancer, and alcohol-related 
liver diseases, Portugal did significantly worse than the mean of the 
high-middle-SDI group.
In comparison to a subset of 11 peer countries of the high- 
middle-SDI group, Portugal presented the second highest risk of early 
deaths from colorectal cancer and ranked fourth for self-harm and  
alcohol-related liver disease. Among countries with the lowest risk, 
Portugal ranked 10th for ischemic heart disease, diabetes mellitus, and 
chronic kidney disease, and ninth for chronic obstructive pulmonary 
disease and road injuries.
As far as the total burden of disease is concerned (DALYs), Portugal 
did significantly better than the mean of the high-middle-SDI group 
in 2016 for ischemic heart disease, stroke, sense organ diseases, dia-
betes mellitus, lung cancer, chronic obstructive pulmonary disease, 
lower respiratory infections, road injuries, and falls. For low back and 
neck pain, depressive disorders, migraine, skin diseases, and colorectal 
cancer, Portugal did significantly worse than the mean of the high-mid-
dle-SDI group.
Among the subset of 11 countries in the high-middle-SDI group, 
Portugal performed better than its peers for sense organ diseases,  
and ranked 10th for ischemic heart disease and ninth for diabetes  
mellitus. On the other hand, Portugal performed worse for depressive  
disorders and ranked second for low back and neck pain, migraine,  
and colorectal cancer.
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Looking at the leading risk factors contributing to premature death 
and comparing with the mean of the high-middle-SDI group, Portugal 
did significantly better for dietary risks, high blood pressure, tobacco 
use, high body mass index, high fasting plasma glucose, high total 
cholesterol, impaired kidney function, air pollution, occupational risks, 
low physical activity, low bone mineral density, and child and maternal 
malnutrition. Portugal did significantly worse for unsafe sex.
Among the 11 peer countries of the high-middle-SDI group selected, 
Portugal was third, with higher levels of alcohol and drug use (with a 
substantial contribution from alcohol consumption) and ranked fifth 
in unsafe sex. Meanwhile, Portugal ranked 10th, only behind Spain and 
Chile, for dietary risks, high systolic blood pressure, tobacco  
consumption, high body mass index, high fasting plasma glucose,  
and high total cholesterol.
Figure 15
































































































































































































































































































































Color key Rate signicantly less than SDI group mean Rate insignicantly different from SDI group mean Rate signicantly greater than SDI group mean
Notes: Data presented are age-standardized YLL rates per 100,000. 
Causes are ordered by crude rates. 
The comparison group is high-middle SDI.






















































































































































































































































































































































































































Notes: Data presented are age-standardized DALYs per 100,000. 
Causes are ordered by crude rates. 
The comparison group is high-middle SDI.
Color key Rate signicantly less than SDI group mean Rate insignicantly different from SDI group mean Rate signicantly greater than SDI group mean
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Figure 17
































































































































































































































































































































Notes: Data presented are age-standardized YLLs per 100,000. 
Risk factors are ordered by crude rates. 
The comparison group is high-middle SDI.
Color key Rate signicantly less than SDI group mean Rate insignicantly different from SDI group mean Rate signicantly greater than SDI group mean

















































































































In comparison to a group of high-income countries,vii Portugal had the lowest life 
expectancy in 1990. Twenty-six years later, life expectancy for Portuguese people is 
similar to the average for these countries, mainly due to a reduction in premature 
deaths from cardiovascular diseases and road injuries.
But even though Portuguese live longer, the number of years lived in full health 
did not increase in the same proportion.
Early deaths – as measured by YLLs – in Portugal between 1990 and 2016 
decreased 25.3%, largely because of reductions in stroke and ischemic heart disease, 
which occurred through improved quality and access to the national health services 
network, especially prehospital emergency care (the programs “Via verde do AVC” 
and “Via verde da doença coronária”).19
The decrease in early deaths (YLLs) from road injuries and neonatal disorders  
was considered a major achievement of this period. Road injuries decreased 75.3%,  
neonatal preterm birth complications 90.3%, and congenital defects 78.5%. The 
reduction in road injuries may be due to the improvements in the road network, 
particularly in the number of motorways available, better vehicle safety, and more 
stringent regulations and law enforcement. The decrease in preterm birth complica-
tions and congenital defects is likely due to a reduction in birth rates and better care 
for preterm infants.
As measured by the number of YLLs, early deaths from lung cancer increased 
substantially more for females (68.1%) than for males (34.4%), although cancer YLLs 
overall were much higher for males, ranging from 3.7 times greater in 2016 to five 
times greater in 1996. The uptick in female lung cancer YLLs is explained by a change 
of smoking habits in women and demands a differentiated intervention.
Early deaths from colorectal cancer, again measured by the number of YLLs, have 
also increased. The change is likely attributable to the effects of an aging population, 
and it does support the need to invest in population-based screening programs. As 
a result of this kind of investment,15 mainly since 2007, YLLs from breast cancer in 
females and cervical cancer have decreased 10.5% and 28.6%, respectively, over the 
past 26 years.
The estimated main risk factor for early mortality in Portugal in 2016 was alcohol 
and drug use, with a fundamental contribution from alcohol consumption. The other 
most important risk factors were poor diet, high systolic blood pressure, tobacco 
consumption, and high body mass index, which encompasses obesity and overweight. 
Health gains could be obtained by expanding efforts to promote healthy diets and 
reduce smoking and alcohol consumption. In the coming years, we will probably see 
the impact of the tobacco law20 implemented in recent years in Portugal.
As Portuguese live longer lives, they increasingly suffer from disabling conditions. 
Low back and neck pain was the most common cause of disability, and disability has 
also risen from osteoarthritis, Alzheimer's disease, and diabetes. Again, the effect 
of an aging population is likely at play here, as rates have stayed relatively flat or 
declined when age structure is made homogeneous through age-standardization. The 
documented effectiveness of treatments for mental disorders and low back and neck 
pain is much lower than the documented effectiveness of treatments for other condi-
tions.21 Nevertheless, Portugal could learn from approaches that have worked well in 
other countries.
Going forward, the Directorate General of Health and IHME will continue to study 
disease burden together, with the possibility of future analysis at the local level. This 
analysis will bring light to health disparities across communities as well as the top 
diseases, injuries, and risk factors that are driving these disparities.
viiSome EU and 
OECD countries.
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Methodological notes
 
Healthy life expectancy measure: 
comparing GBD and Eurostat approaches
To estimate the number of years lived with disability for the Portuguese 
population, GBD studies take into account the prevalence of diseases 
and injuries. These values are weighted by their specific disability 
weights, which reflect the severity of the different conditions. These 
disability weights are developed through international surveys of the 
general public.
Healthy life expectancy (HALE) is a summary measure that adjusts 
overall life expectancy by the amount of time lived in less than perfect 
health. This is calculated by subtracting a proportion of healthy time 
lost in a life table based on the average rate of YLDs by age. This is a 
more sophisticated method of adjusting life expectancy for nonfatal 
loss than the Healthy Life Expectancy (HLE) approach. This approach 
is based on a survey question of self-perceived longstanding activity 
limitations in usual activities due to health problems from a European 
health module that is integrated within the data collection of EU sta-
tistics on income and living conditions (EU-SILC). The HLE calculation 
assumes the proportion above the threshold does not contribute life 
years to the HLE measure.
Description of Eurostat’s approach to obtain HLE indicators is 
relevant to this report. This is because Portugal’s Ministry of Health 
adopted the Eurostat indicator Healthy Life Years to measure progress 
toward the NHP goal of increasing the healthy life expectancy of the 
Portuguese population. Due to the use of self-reported data, Eurostat’s 
HLE indicator is, to a certain extent, affected by respondents’ subjective 
perception as well as by their social and cultural background.
Another major methodological difference between GBD and Eurostat 
approaches is the reference population for disability data. GBD uses 
prevalence values for total population, whereas Eurostat excludes 
people living in collective households (the general coverage of EU-SILC 
is all private households and their members).
Input data used in GBD 2016 to generate estimates for Portugal for alcohol use
Year Start Year End Citation 
2011 2011
Börsch-Supan, A. (2013). Survey of Health, Ageing and Retirement in Europe (SHARE) Wave 4. Release version: 
1.1.1. SHARE-ERIC. Data set. DOI: 10.6103/SHARE.w4.111
2002 2002
European Commission (2012): Eurobarometer 57.2OVR (Apr-Jun 2002). European Opinion Research Group 
(EORG), Brussels. GESIS Data Archive, Cologne. ZA3641 Data file Version 1.0.1, doi:10.4232/1.10951
2003 2003
European Commission (2012): Eurobarometer 59.0 (Jan-Feb 2003). European Opinion Research Group (EORG), 
Brussels. GESIS Data Archive, Cologne. ZA3903 Data file Version 1.0.1, doi:10.4232/1.11352
2006 2006
European Commission (2012): Eurobarometer 66.2 (Oct-Nov 2006). TNS OPINION &amp; SOCIAL, Brussels 
[Producer]. GESIS Data Archive, Cologne. ZA4527 Data file Version 1.0.1, doi:10.4232/1.10981
2009 2009
European Commission (2012): Eurobarometer 72.3 (Oct 2009). TNS OPINION &amp; SOCIAL, Brussels 
[Producer]. GESIS Data Archive, Cologne. ZA4977 Data file Version 2.0.0, doi:10.4232/1.11140
Input data used in GBD 2016 to generate estimates for Portugal for drug use
Year Start Year End Citation 
2005 2005
EMCDDA. European Monitoring Centre for Drugs and Drug Addiction Statistical Bulletin 2009. Lisbon, 
Portugal: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
2012 2012
EMCDDA. European Monitoring Centre for Drugs and Drug Addiction Statistical Bulletin 2016. Lisbon, 
Portugal: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2016
Input data used in GBD 2016 to generate estimates for Portugal for unsafe sex
Year Start Year End Citation 
2006 2012
ECDC, WHO/Europe. HIV/AIDS Surveillance in Europe 2012. Stockholm, Sweden: European Centre for Disease 
Prevention and Control, 2013
2013 2013
ECDC, WHO/Europe. HIV/AIDS Surveillance in Europe 2013. Stockholm, Sweden: European Centre for Disease 
Prevention and Control, 2014
2014 2014
ECDC, WHO/Europe. HIV/AIDS Surveillance in Europe 2014. Stockholm, Sweden: European Centre for Disease 
Prevention and Control, 2015
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Sustainable Development Goals:  
the framework 
The United Nations established, in September 2015, the Sustainable 
Development Goals (SDGs), which specify 17 universal goals, 169 
targets, and 232 indicators leading up to 2030. The GBD 2016 study 
provides estimates for 37 health-related SDG indicators for 188 coun-
tries from 1990 to 2016, as well as projections, based on past trends, 
from 2017 to 2030. These 37 SDG indicators were used to construct the 
health-related SDG index, a summary measure of overall performance 
across the health-related SDGs. 
Health-related indicators are indicators that directly involve health 
services, health outcomes, and risk factors with well-established causal 
connections to health.
The aster plot in Figure 14 shows, for a given country and year, each 
of the 37 health-related SDG indicators as individual arms, color-coded 
by SDG target. The number in the middle of this diagram is the 
health-related SDG index value. The numbers associated with each arm 
of the sunburst are “index values” (on a scale of 0 to 100) for a given 
health-related SDG indicator, identified by abbreviated descriptions. 
The relative length of each sunburst arm represents a given indicator’s 
“index value,” such that a longer arm reflects a value closer to 100 (best 
performance) and a shorter arm reflects a value closer to 0 (worst per-
formance).
These indices are based on individual health-related SDG indicators 
that are scaled to provide an easy way to directly compare overall per-
formance across geographies, over time, and by index type. GBD 2016 
also includes estimates or unscaled values, i.e., the underlying indicator 
values – deaths per 100,000, proportion of children under 5 who are 
overweight, cases per 1,000, and so on.
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Annex: Health-related SDG indicators 
for Portugal, 2016 (GBD estimates)







Goal 1: End poverty in all its forms everywhere. 1    
Target 1.5: By 2030, build the resilience of the poor and those in vulnerable situations and reduce 
their exposure and vulnerability to climate-related extreme events and other economic, social and 
environmental shocks and disasters.
1.5    





Goal 2: End hunger, achieve food security and improved nutrition, and promote 
sustainable agriculture. 2    
Target 2.2: By 2030, end all forms of malnutrition, including achieving, by 2025, the 
internationally agreed targets on stunting and wasting in children under 5 years of age, and 
address the nutritional needs of adolescent girls, pregnant and lactating women and older 
persons.
2.2    
Indicator 2.2.1: Prevalence of stunting among children under 5 years of age 2.2.1 Percent (%)
Equal to or less 
than 0.5% by 
2030
1.5
Indicator 2.2.2a: Prevalence of wasting among children under 5 years of age 2.2.2a Percent (%)
Equal to or less 
than 0.5% by 
2030
1.1
Indicator 2.2.2b: Prevalence of overweight among children aged 2 to 4 years 2.2.2b Percent (%)
Equal to or less 
than 0.5% by 
2030
31.7
Goal 3: Ensure healthy lives and promote well-being for all at all ages 3    
Target 3.1: By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live 
births. 3.1    
Indicator 3.1.1: Maternal mortality ratio (maternal deaths per 100,000 live births) in women 









Indicator 3.1.2: Proportion of births attended by skilled health personnel (doctors, nurses, 
midwives, or country-specific medical staff [e.g., clinical officers]) 3.1.2 Percent (%)




Target 3.2: By 2030, end preventable deaths of newborns and children under 5 years of age, with 
all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and 
under 5 mortality to at least as low as 25 per 1,000 live births.
3.2    





Equal to or less 
than 25 deaths 
per 1,000 live 
births by 2030
3.1
Indicator 3.2.2: Neonatal mortality rate (probability of dying during the first 28 days of life per 




Equal to or less 
than 12 deaths 
per 1,000 live 
births by 2030
1.6
Target 3.3: By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical 
diseases and combat hepatitis, water-borne diseases and other communicable diseases. 3.3    
Indicator 3.3.1: Age-standardized rate of new HIV infections (per 1,000 population) 3.3.1 Cases per 1,000
Equal to or less 
than 0.005 per 
1,000 by 2030
0.6
Indicator 3.3.2: Age-standardized rate of tuberculosis cases (per 100,000 population) 3.3.2 Cases per 100,000
Equal to or less 
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Indicator 3.3.3: Age-standardized rate of malaria cases (per 1,000 population) 3.3.3 Cases per 1,000
Equal to or less 
than 0.005 per 
1,000 by 2030
0.0





Indicator 3.3.5: Age-standardized prevalence of the sum of 15 neglected tropical diseases 
(NTDs) 3.3.5 Percent (%)
Equal to or less 
than 0.5% by 
2030
0.9
Target 3.4: By 2030, reduce by one third premature mortality from NCDs through prevention and 
treatment and promote mental health and well-being. 3.4    
Indicator 3.4.1: Age-standardized death rate due to cardiovascular disease, cancers, diabetes, 




third by 2030 232.8
Indicator 3.4.2: Age-standardized death rate due to self-harm (per 100,000 population) 3.4.2 Deaths per 100,000
Reduce by one-
third by 2030 9.7
Target 3.5: Strengthen the prevention and treatment of substance abuse, including narcotic drug 
abuse and harmful use of alcohol. 3.5    
Indicator 3.5.2: Risk-weighted prevalence of alcohol consumption, as measured by the 





Target 3.6: By 2020, halve the number of global deaths and injuries from road traffic accidents. 3.6    
Indicator 3.6.1: Age-standardized death rate due to road injuries (per 100,000 population) 3.6.1 Deaths per 100,000
Reduce by 50% 
by 2020 8.5
Target 3.7: By 2030, ensure universal access to sexual and reproductive health-care services, 
including for family planning, information and education, and the integration of reproductive 
health into national strategies and programs.
3.7    
Indicator 3.7.1: Proportion of women of reproductive age (15 to 49 years) who have their need 
for family planning satisfied with modern contraception methods 3.7.1 Percent (%)




Indicator 3.7.2: Number of live births per 1,000 women aged 10 to 14 years and women aged 
15 to 19 years 3.7.2






Target 3.8: Achieve universal health coverage, including financial risk protection, access to quality 
essential health-care services and access to safe, effective, quality and affordable essential 
medicines and vaccines for all.
3.8    
Indicator 3.8.1: Coverage of essential health services, as defined by a UHC index of the 
coverage of 9 tracer interventions and risk-standardized death rates from 32 causes amenable 
to personal healthcare
3.8.1 Index value (0-100)




Target 3.9: By 2030, substantially reduce the number of deaths and illnesses from hazardous 
chemicals and air, water and soil pollution and contamination. 3.9    
Indicator 3.9.1: Age-standardized death rate attributable to household air pollution and 







Indicator 3.9.2: Age-standardized death rate attributable to unsafe water, sanitation, and 















Target 3.a: Strengthen the implementation of the World Health Organization Framework 
Convention on Tobacco Control in all countries, as appropriate. 3.a    
Indicator 3.a.1: Age-standardized prevalence of daily smoking among populations aged 10 





Target 3.b: Support the research and development of vaccines and medicines for the 
communicable and non-communicable diseases that primarily affect developing countries, 
provide access to affordable essential medicines and vaccines, in accordance with the Doha 
Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing 
countries to use to the full the provisions in the Agreement on Trade-Related Aspects of 
Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, 
provide access to medicines for all.
3.b    
Indicator 3.b.1: Coverage of eight vaccines, conditional on inclusion in national vaccine 
schedules, in target populations 3.b.1 Percent (%)











Goal 5: Achieve gender equality and empower all women and girls. 5    
Target 5.2: Eliminate all forms of violence against all women and girls in the public and private 
spheres, including trafficking and sexual and other types of exploitation. 5.2    
Indicator 5.2.1: Age-standardized prevalence of women aged 15 years and older who 
experienced physical or sexual violence by an intimate partner in the last 12 months 5.2.1 Percent (%)
Equal to or less 
than 0.5% by 
2030
14.3
Goal 6: Ensure availability and sustainable management of water and sanitation 
for all. 6    
Target 6.1: By 2030, achieve universal and equitable access to safe and affordable drinking water 
for all. 6.1    
Indicator 6.1.1: Risk-weighted prevalence of populations using  unsafe or unimproved water 
sources, as measured by the summary exposure value (SEV) for unsafe water 6.1.1 Percent (%)
Equal to or less 
than 1% by 
2030
1.1
Target 6.2: By 2030, achieve access to adequate and equitable sanitation and hygiene for all 
and end open defecation, paying special attention to the needs of women and girls and those in 
vulnerable situations.
6.2    
Indicator 6.2.1a: Risk-weighted prevalence of populations using  unsafe or unimproved 
sanitation, as measured by the summary exposure value (SEV) for unsafe sanitation 6.2.1a Percent (%)
Equal to or less 
than 1% by 
2030
5.7
Indicator 6.2.2b: Risk-weighted prevalence of populations without access to a handwashing 
facility, as measured by the summary exposure value (SEV) for unsafe hygiene 6.2.1b Percent (%)
Equal to or less 
than 1% by 
2030
4.0
Goal 7: Ensure access to affordable, reliable, and sustainable modern energy for 
all. 7    
Target 7.1: By 2030, ensure universal access to affordable, reliable and modern energy services. 7.1    
Indicator 7.1.2: Risk-weighted prevalence of household air pollution, as measured by the 
summary exposure value (SEV) for household air pollution 7.1.2 Percent (%)
Equal to or less 
than 1% by 
2030
0.6
Goal 8: Promote sustained, inclusive and sustainable economic growth, full and 
productive employment and decent work for all. 8    
Target 8.8: Protect labor rights and promote safe and secure working environments for all 
workers, including migrant workers, in particular women migrants, and those in precarious 
employment.
8.8    
Indicator 8.8.1: Age-standardized all-cause disability-adjusted life year (DALY) rates 







Goal 11: Make cities and human settlements inclusive, safe, resilient, and 
sustainable. 11    
Target 11.5: By 2030, significantly reduce the number of deaths and the number of people 
affected and substantially decrease the direct economic losses relative to global gross domestic 
product caused by disasters, including water-related disasters, with a focus on protecting the poor 
and people in vulnerable situations.
11.5    
Target 11.6: By 2030, reduce the adverse per capita environmental impact of cities, including by 
paying special attention to air quality and municipal and other waste management. 11.6    
Indicator 11.6.2: Population-weighted mean levels of fine particulate matter smaller than 2.5 
microns (PM2.5)





Goal 16: Promote peaceful and inclusive societies for sustainable development, 
provide access to justice for all and build effective, accountable, and inclusive 
institutions at all levels.
16    
Target 16.1: Significantly reduce all forms of violence and related death rates everywhere 16.1    
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Indicator 16.1.3: Age-standardized prevalence of physical or sexual violence experienced by 





Indicator 16.2.3: Age-standardized prevalence of women and men aged 18-29 years who 
experienced sexual violence by age 18 16.2.3 Percent (%)
Equal to or less 
than 0.5% by 
2030
11.2
Goal 17: Strengthen the means of implementation and revitalize the global 
partnership for sustainable development. 17    
Target 17.19: By 2030, build on existing initiatives to develop measurements of progress on 
sustainable development that complement gross domestic product, and support statistical 
capacity-building in developing countries.
17.19    
Indicator 17.19.2c: Percentage of well-certified deaths by a vital registration (VR) system 
among a country's total population 17.19.2c Percent (%)




Source: Institute for Health Metrics and Evaluation (IHME). Health-related SDGs. Seattle, WA: IHME, University of Washington, 2017. 
Available from http://vizhub.healthdata.org/sdg. (Accessed 25 September 2017)

INSTITUTE FOR HEALTH METRICS AND EVALUATION
UNIVERSITY OF WASHINGTON
INSTITUTE FOR HEALTH METRICS AND EVALUATION
2301 Fifth Avenue, Suite 600 







Alameda D. Afonso Henriques, 45
1049-005 Lisboa
Portugal
Telephone: +351 218 430 500
Fax: +351 218 430 530/1
Email: geral@dgs.min-saude.pt
http://www.dgs.pt
